发明申请
- 专利标题: Compounds With Kv4 Ion Channel Activity
- 专利标题(中): 具有Kv4离子通道活性的化合物
-
申请号: US11793559申请日: 2005-12-20
-
公开(公告)号: US20080039442A1公开(公告)日: 2008-02-14
- 发明人: Petra Blom , Jan de Kerpel , Eric Fourmaintraux , Titus Kaletta , Dirk Leysen
- 申请人: Petra Blom , Jan de Kerpel , Eric Fourmaintraux , Titus Kaletta , Dirk Leysen
- 申请人地址: BE Zwijnaarde B-9052
- 专利权人: Devgen NV
- 当前专利权人: Devgen NV
- 当前专利权人地址: BE Zwijnaarde B-9052
- 优先权: EP04447288.4 20041221; EP05077173.2 20050922
- 国际申请: PCT/EP05/13715 WO 20051220
- 主分类号: A61K31/343
- IPC分类号: A61K31/343 ; A61K31/357 ; A61K31/381 ; A61K31/404 ; A61K31/4155 ; A61K31/423 ; A61K31/433 ; A61K31/4525 ; A61K31/47 ; A61K31/4965 ; A61K31/497 ; A61K31/5377 ; A61K31/55 ; A61P25/00 ; A61P9/00 ; C07D209/42 ; C07D215/48 ; C07D231/10 ; C07D233/18 ; C07D241/02 ; C07D263/58 ; C07D265/30 ; C07D285/06 ; C07D307/82 ; C07D307/85 ; C07D307/87 ; C07D319/16 ; C07D333/56 ; C07D333/70 ; C07D405/02 ; C07D409/12 ; C07D413/02 ; C07D493/00
摘要:
The present invention relates to compounds that interact with ion channels. In particular, the invention relates to compounds having the structural Formula (I), (II), (III) or (IV), stereoisomers, tautomers, racemics, prodrugs, metabolites thereof, or a pharmaceutically acceptable salt and/or solvate thereof, Formula (I), (II), (III), (IV), wherein X1, X2, Y, Z, W, R1, R8, R9, R10, L, A, z, and n have the meaning defined in claim 1. The invention also relates to methods for preparing said compounds, to pharmaceutical compositions comprising said compounds, and to the use of said compounds in methods for treatment of the human and animal body.
信息查询
IPC分类: